icon
icon
icon
icon
Upgrade
Upgrade

News /

Articles /

WW Plunges 28.47% Amid Lilly Partnership

Mover TrackerFriday, May 2, 2025 7:36 am ET
1min read

On May 2, 2025, ww experienced a significant drop of 28.47% in pre-market trading, marking a notable shift in its stock performance.

WW International Inc. has recently announced a strategic partnership with eli lilly, focusing on streamlining access to Lilly's weight-loss drug, Zepbound. This collaboration aims to enhance the availability of Zepbound single-dose vials for WeightWatchers Clinic members, particularly those with appropriate prescriptions. The surge in Zepbound prescriptions and the effectiveness of the app's tracking system in reducing drop-off rates have positioned WW for potential scalability with other therapies.

The partnership has been met with enthusiasm, as Zepbound usage among WeightWatchers Clinic members has more than doubled in recent months. This surge in demand highlights the growing acceptance and effectiveness of the drug within the WeightWatchers community. The streamlined access to Zepbound through LillyDirect® Pharmacy Provider is expected to further boost member satisfaction and retention.

Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.